Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia
Launched by GEORGETOWN UNIVERSITY · Feb 2, 2016
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Primary Progressive Aphasia (PPA; including Frontotemporal Dementia, Semantic Dementia, or a similar condition) or Diagnosis of Alzheimer's Disease
- • At least 10 years of education
- • Ability to follow spoken instructions
- • Medically stable
- • First language is English, or fluent in English since childhood
- • Willing to participate over a period of two years
- Exclusion Criteria:
- • No history of additional neurological problems
- • No history of substance abuse or psychiatric problems
Trial Officials
Aaron Meyer, PhD
Principal Investigator
Georgetown University
About Georgetown University
Georgetown University is a prestigious academic institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Georgetown University leverages its extensive resources and expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among multidisciplinary teams, emphasizing ethical practices and adherence to regulatory standards. With a focus on translating scientific discoveries into clinical applications, Georgetown University plays a vital role in enhancing patient care and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Washington, District Of Columbia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
